Listen "CNTF Treatment of MacTel2"
Episode Synopsis
We discuss clinical trials using CNTF to treat MacTel Type 2 with Dr. John Pollack, Chief Medical Officer of Neurotech Pharmaceuticals.
More episodes of the podcast Retina Synthesis
Stem Cell Therapy for Geographic Atrophy
19/11/2025
8 mg Aflibercept in Diabetic Macular Edema
08/10/2025
Subretinal Gene Therapy for Neovascular AMD
03/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.